Please login to the form below

Not currently logged in
Email:
Password:

W2O continues global expansion with ISO.health acquisition

Acquisition of London-based agency extends reach into Europe

W2o

W2O, an independent provider of marketing communications to the healthcare sector, has announced its acquisition of ISO.health. 

ISO.health is a London-based medical communications agency, and was founded in 2016 by Suzanne Jacobs, Oli Burnham and Isabel Gibson.

It is comprised of industry experts adept at developing and delivering omnichannel medical and scientific educational programmes for pharmaceutical, biotech and life sciences companies/organisations.

Following this acquisition, W2O will gain a European-based scientific and medical communications arm which has an established client base. The agency has extensive experience in working with healthcare companies across all therapeutic areas and stages of development.

“Since our company’s inception, our primary focus has centred on looking through the lens of healthcare professionals, patients and advocacy groups to develop holistic medical communications campaigns, rooted in science, that drive real value to our clients,” said Jacobs, partner at W2O, ISO.

ISO also has core expertise in strategic and operational planning, stakeholder mapping, opinion leader development, advisory board management and scientific narration among others areas.

“With healthcare brands having a predominantly international audience, the importance of leading with science is essential as it represents the backbone of a brand’s global narrative.

"ISO is exceptionally capable at translating often highly complex data into insightful, effective language with relevant media and that reaches and resonates with multiple stakeholders across geographies,” said Jim Weiss, W2O founder and CEO.

“Together we are building a global leader in analytics-driven medical and scientific marketing communications,” he added.

7th November 2019

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics